Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cynata Therapeutics Ltd V.CYP


Primary Symbol: CYYNF

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.


OTCPK:CYYNF - Post by User

Post by GarryJan1on Jan 21, 2021 11:38am
313 Views
Post# 32345159

Looks like our north neighbor NRM has

Looks like our north neighbor NRM has just as much lithium as us. They are also next to the road and accross the road from ALB brine ponds. Lots of upside as well. I now own both.

Noram Completes CVZ-66: Ends in Mineralization at 462ft Continuing to Confirm Resource Dip and Direction

VANCOUVER, BC / ACCESSWIRE / January 21, 2021 / Noram Ventures Inc. ("Noram" or the "Company") (TSXV:NRM)(FSE:N7R)(OTCQB:NRVTF) is pleased to announce the completion of its 6th hole of the Phase V 12-hole drill program. CVZ-66 was completed to a depth of 462ft and is one of the four deepest holes drilled to date showing mineralization below 400ft. An intersection of approximately 301 ft of favourable claystones was evident and drilling ended in blue claystone which has been shown in past programs to host significant amounts of lithium.

Figure 1a) Strip Log of CVZ-66 outlining the various claystone types encountered at depth from the surface to 462ft b) Zeus Property map showing a) location of current Indicated and Inferred resources at >900ppm Li cut-off; b) location of drill sites completed or in progress (seen in green) to date for the Phase V 2020 program. Proposed drill sites not yet explored indicated in white.

From (ft)

To (ft)

Lithology

0

122

Surface Gravel

122

161

Brown Sandy Mudstone

161

213

Olive Claystone/Mudstone

213

269

Blue Claystone/Mudstone

269

342

Blue-Black Claystone/Mudstone

342

462

Blue Claystone/Mudstone


Table 1 - Summary of Figure 1a Strip Log, describing the lithologies of CVZ-66 from surface to depth of 462ft.

"This is an important drill hole for Noram. The Company has not previously drilled in this area, nor at these depths; consequently, the results will significantly impact the resource modelling. From visual inspection alone, it appears that CVZ-66 once again confirms our theories on the uniform presence of the lakebed claystone deposits over a huge area or Noram's claim block" commented Brad Peek, consulting geologist and Qualified Person for this and all 4 of the previous drilling phases of Noram's Zeus lithium property


<< Previous
Bullboard Posts
Next >>